Literature DB >> 10647622

Biologic mechanisms of 89SrCl2 incorporation into type I collagen during bone mineralization.

J Davis1, N D Cook, R J Pither.   

Abstract

UNLABELLED: 89SrCl2 is currently used as a palliative treatment for painful osseous metastases associated with an osteoblastic reaction in bone. However, the underlying biologic mechanism by which 89SrCl2 accumulates at these lesions and mediates palliation remains unclear. The aim of this study was therefore to elucidate this mechanism.
METHODS: An in vitro cell biologic model, incorporating the MC3T3-E1 murine osteoblast cell line, was established to replicate the process of collagen production and mineralization. Experiments were performed to investigate the cellular association of 89SrCl2 and 45CaCl2 with both MC3T3-E1 cells and the PC-3 human prostate adenocarcinoma cell line.
RESULTS: No evidence of intracellular localization of 89SrCl2 or 45CaCl2 was found for either cell line. Localization of radiolabel was seen to be associated with MC3T3-E1 cells but only in cultures that had undergone both differentiation and mineralization. The association of 89SrCl2 was inhibited by the alkaline phosphatase inhibitor levamisole, and extracellular localization of 89SrCl2 was confirmed by microautoradiography.
CONCLUSION: 89SrCl2 acts as a calcium mimic and, as such, becomes associated with the collagen matrix produced by the MC3T3-E1 cells during collagen mineralization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647622

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

Review 2.  Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.

Authors:  Kazuma Ogawa; Atsushi Ishizaki
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

3.  Evaluation of Chlorella as a Decorporation Agent to Enhance the Elimination of Radioactive Strontium from Body.

Authors:  Kazuma Ogawa; Tadahisa Fukuda; Jaegab Han; Yoji Kitamura; Kazuhiro Shiba; Akira Odani
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

4.  Complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum to enhance excretion of radioactive strontium from the body.

Authors:  Kazuma Ogawa; Miho Aoki; Sumi Kadono; Akira Odani
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.